Additional Advice

The following should be referred to the pharmacist:

  • Pregnant/breastfeeding women
  • Customers using contact lenses or other eye products
  • Children aged under two years
  • Customers who may have an eye injury/foreign body in the eye
  • The eye is inflamed and there is a rash on the scalp/face
  • The pupil of the eye looks unusual or cloudy
  • The eyes are sensitive to light
  • Customers who have had eye surgery/laser treatment
  • Customers with glaucoma or dry eye syndrome.

How to use Optrex Infected Eye

Ointment: Apply a small amount in the affected eye three to four times daily for five days.

Drops: Apply one drop to the affected eye every two hours for the first 48 hours. Thereafter, apply one drop every four hours. Drops should be used during waking hours only. The product must be stored between 2-8°C.

Click for references and product information

Thank you for learning with us

Now that you have finished the Mini Tutor, why not try one of our other P13B modules?

Reference: 1. https://www.medicines.org.uk/emc/product/612/smpc

Optrex Infected Eye Drops: Chloramphenicol 0.5% w/v. One drop instilled into the infected eye every 2 hours for the first 48 hours and 4 hourly thereafter. To be used during waking hours only. The course of treatment is 5 days. Treatment should continue for 5 days even if symptoms improve. MRRP: £6.49. Indications: Treatment of acute bacterial conjunctivitis. Legal category: P. License holder: Optrex Limited, Slough, SL1 3UH. Information about this product, including adverse reactions, precautions, contraindications, and method of use can be found at: https://www.medicines.org.uk/emc/medicine/23300

Optrex Bacterial Conjunctivitis 1% w/w Eye Ointment: 10 mg Chloramphenicol (1% w/w). Apply a small amount in the affected eye 3 to 4 times daily for 5 days. Suitable for day or night time use. MRRP: £5.99. Indications: For the treatment of acute bacterial conjunctivitis in adults and children aged 2 years and over. Legal category: P. Product license holder: Medicom Healthcare Ltd, Hants, PO14 4PJ, UK. Information about this product, including adverse reactions, precautions, contraindications, and method of use can be found at: https://www.medicines.org.uk/emc/product/7299/smpc

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Reckitt Benckiser Healthcare (UK) Ltd on: 0333 200 5345. Date of preparation: June 2020. RB-M-07370